Analyst talks Biotech sector, offers three picks for 2021
Multiple small-and mid-cap stocks have "exciting stories" to tell investors in 2021. One analyst recommends Olema Pharma, Morphic Holding, and Schrodinger The biotechnology exchange-traded fund SPDR S&P Biotech ETF (NYSE: XBI) is up around 50% in 2020 and Jefferies’ managing director Michael Yee says the valuations are not only justified but sustainable in 2021. ‘Exciting stories’ for 2021 While looking at the Biotech sector, it is important to separate the small group of COVID-19 vaccine makers from the overall biotech innovation thesis, Yee said Tuesday on CNBC’s “Closing Bell....
Source: invezz.com